Compositions and methods for analyte detection
Methods of analyzing nucleic acids of a cell are provided.
1. A method for identifying an analyte in a cell or tissue sample, comprising:
(a) binding a detection reagent to said analyte in said cell or tissue sample, wherein said detection reagent comprises: (i) a probe that binds to said analyte and (ii) a predetermined sequence that identifies said analyte, wherein said cell or tissue sample is on a solid support;
(b) sequencing said predetermined sequence in a temporally sequential manner to detect a plurality of optical signal signatures from said cell or tissue sample, wherein each nucleobase of said predetermined sequence that is sequenced generates a distinct optical signal signature corresponding to said nucleobase, and wherein one of said distinct optical signal signatures is an optical signal signature having no color; and
(c) using a temporal order of said plurality of optical signal signatures to identify said analyte in said cell or tissue sample.
2. The method of claim 1 , wherein said analyte is a protein analyte, wherein said probe comprises an antibody, and wherein said antibody is conjugated to a nucleic acid molecule comprising said predetermined sequence.
3. The method of claim 1 , wherein said analyte is a nucleic acid analyte, wherein said detection reagent is a nucleic acid molecule, and wherein said probe comprises a probe sequence complementary to a sequence of said nucleic acid analyte.
4. The method of claim 3 , wherein said nucleic acid analyte is a ribonucleic acid (RNA) analyte.
5. The method of claim 4 , wherein said detection reagent is a linear nucleic acid molecule.
6. The method of claim 5 , further comprising, prior to said sequencing, (i) circularizing said linear nucleic acid molecule to obtain a circularized detection reagent; and (ii) amplifying said circularized detection reagent by rolling circle amplification.
7. The method of claim 6 , wherein circularizing said linear nucleic acid molecule comprises use of a ligase.
8. The method of claim 1 , wherein said detection reagent comprises a plurality of predetermined sequences that identify said analyte and wherein said sequencing comprises sequencing said plurality of predetermined sequences.
9. The method of claim 1 , wherein said predetermined sequence comprises at least three nucleotides.
10. The method of claim 1 , wherein said predetermined sequence is 5-30 nucleotides in length.
11. The method of claim 1 , wherein said sequencing comprises sequencing by synthesis.
12. The method of claim 1 , wherein said sequencing comprises sequencing by ligation.
13. The method of claim 1 , wherein each sequencing step of said sequencing determines one nucleobase of said predetermined sequence.
14. The method of claim 1 , wherein, in (b), at least one of said distinct optical signal signatures is a compound optical signature comprising two or more fluorescent colors.
15. The method of claim 1 , wherein said cell or tissue sample is a tissue section on a microscopy slide.
16. The method of claim 15 , wherein said tissue section is a fixed, paraffin-embedded tissue section.
17. The method of claim 15 , further comprising, prior to (a), fixing or permeabilizing said tissue section.
18. The method of claim 1 , further comprising, prior to said sequencing, amplifying said detection reagent.
19. A method for identifying an analyte at a spatial location of a cell or tissue sample, comprising:
(a) binding a detection reagent to said analyte at said spatial location in said cell or tissue sample, wherein said cell or tissue sample is mounted on a solid support, and wherein said detection reagent comprises: (i) a probe that binds to said analyte and (ii) a predetermined sequence that identifies said analyte;
(b) sequencing said predetermined sequence in a temporally sequential manner to detect a plurality of optical signal signatures at said spatial location, wherein each nucleobase of said predetermined sequence that is sequenced generates a distinct optical signal signature corresponding to said nucleobase, and wherein one of said distinct optical signal signatures is a signal signature having no color; and
(c) using a temporal order of said plurality of optical signal signatures detected at said spatial location to identify said analyte at said spatial location in said cell or tissue sample.
20. The method of claim 19 , further comprising, prior to said sequencing, amplifying said detection reagent.
21. The method of claim 19 , wherein said analyte is a ribonucleic acid (RNA) analyte and wherein said detection reagent is a linear nucleic acid molecule.
22. The method of claim 21 , further comprising, prior to said sequencing, (i) circularizing said linear nucleic acid molecule to obtain a circularized detection reagent and (ii) amplifying said circularized detection reagent by rolling circle amplification.
23. The method of claim 19 , wherein, in (b), at least one of said distinct optical signal signatures is a compound optical signature comprising two or more fluorescent colors.
24. The method of claim 19 , wherein said detection reagent comprises a plurality of predetermined sequences that identify said analyte and wherein said sequencing comprises sequencing said plurality of predetermined sequences.
25. The method of claim 19 , wherein said predetermined sequence comprises at least three nucleotides.
26. A method for identifying a plurality of RNA analytes in a cell or tissue sample, comprising:
(a) contacting said cell or tissue sample with a plurality of detection reagents, wherein said cell or tissue sample is mounted on a solid support, wherein each subpopulation of said plurality of detection reagents targets at least one different RNA analyte of said plurality of RNA analytes, wherein each detection reagent of said plurality of detection reagents is a nucleic acid molecule comprising (i) a probe targeting an RNA analyte of said plurality of RNA analytes and (ii) a predetermined sequence that identifies said RNA analyte, wherein said predetermined sequence is at least three nucleotides in length;
(b) removing unbound detection reagents from said cell or tissue sample;
(c) sequencing said predetermined sequence in a temporally sequential manner to detect a plurality of optical signal signatures at a spatial location in said cell or tissue sample, wherein each nucleobase of said predetermined sequence that is sequenced generates a distinct optical signal signature corresponding to said nucleobase, and wherein one of said distinct optical signal signatures is a signal signature having no color, and wherein a temporal order of said plurality of optical signal signatures detected at said spatial location identifies a subpopulation of said plurality of detection reagents; and
(d) using said temporal order of said plurality of optical signal signatures detected at said spatial location to identify said plurality of RNA analytes in said cell or tissue sample.
27. The method of claim 26 , further comprising, prior to said sequencing, amplifying a detection reagent of said plurality of detection reagents.
28. The method of claim 26 , wherein a detection reagent of said plurality of detection reagents is a linear nucleic acid molecule.
29. The method of claim 28 , further comprising, prior to said sequencing, (i) circularizing said linear nucleic acid molecule to obtain a circularized detection reagent and (ii) amplifying said circularized detection reagent by rolling circle amplification.
30. The method of claim 14 , wherein said two or more fluorescent colors are detected in multiple channels.